Knowledge Center
Patent / Jan 01, 1973
16.beta.-Methyl-17-hydroxypregna-1,4,9(11)-triene-3,20-dione
Source:
GB 1397267
The title compd. (I), useful as intermediate for the manuf. of betametasone, was prepd. Partial ketalization of the trioxo compd. (II), KBH4 redn. of the resulting oxo compd. (III), and subsequent dehydration by MeSO2Cl contg. SO3 gave the epoxypregnene (IV). Grignard reaction of IV with MeMgBr gave the methylhydroxy deriv. (V) and subsequent deketalization the dione (VI), which on 2-step bromination-dehydrobromination or 1-step dehydrogenation by dichlorodicyanobenzoquinone led to I.
Also in the Knowledge Center
/ Oct 13, 2021
Evaluation of the Relaxation State of Amorphous Itraconazole Using Solution Calorimetry
Read more
Scientific Article
/ Oct 18, 2021
Spray-Dried Composite Formulation Containing DSPC for Lung Sustained Release
Read more
Scientific Article
/ Oct 17, 2021
Understanding Dry Powder Inhalers Formulations: Role of Surface Polarity of lactose mixtures
Read more
Scientific Article